Skip to content
akaturk Academic measurement

Article detail · 2009

Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease

Journal

Coronary Artery Disease

ISSN 0954-6928

YÖKSİS OpenAlex SJR Q1 JCR Q3 Citations 12 Percentile 70.9% FWCI 0.53
Year
2009
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue Coronary Artery Disease
  • Catalog match (ISSN) Coronary Artery Disease
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

OpenAlex · English

OBJECTIVES: Growing evidence has indicated the potential clinical usefulness of measuring different forms of cytokeratin 18 in patient sera (M30 antigen for apoptosis and M65 antigen for necrosis) for distinguishing different forms of cell death. Preliminary data have reported altered levels of cytokeratin 18 fragments in patients with acute coronary syndrome (ACS) and ischemic heart disease. In this study, serum levels of M30 and M65 were measured in 74 patients with ACS [including 17 cases with unstable angina and 57 patients with acute myocardial infarction (AMI)], 25 patients with stable angina, and 23 controls. METHODS: In patients with ACS, serial measurements of M30 and M65 were obtained, and for each patient, the following values were determined: (i) values at admission, (ii) values obtained 24 h after symptom onset, and (iii) values obtained at 48 h after symptom onset. The severity of coronary atherosclerosis was expressed using the Gensini score. RESULTS: On admission, M30 and M65 levels in ACS patients were similar to those observed in stable angina patients and control participants. In AMI patients, serum levels of M30 peaked at 24 h and declined thereafter at 48 h. Notably, serum levels of M30 measured at 24 h correlated significantly and positively with the extent of coronary artery disease as measured by the Gensini score in AMI patients (r = 0.253, P<0.05). CONCLUSION: Serum levels of the apoptotic marker M30 peak at 24 h after AMI and reflects the extent of coronary artery disease in this patient group.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

12 citations

OpenAlex cited_by_count (cache / database)

12 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. Successful treatment of total occluded innominate artery in a patient with subclavian steal syndrome 2016 Citations 13 · OpenAlex
  2. Evaluation of the Relation between Vitamin D and Serum Omentin and Vaspin Levels in Women 2016 Citations 13 · OpenAlex
  3. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation 2022 Citations 12 · OpenAlex
  4. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation 2022 Citations 12 · OpenAlex
  5. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation. 2022 Citations 12 · OpenAlex
  6. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation 2022 Citations 12 · OpenAlex
  7. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation 2022 Citations 12 · OpenAlex
  8. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation 2022 Citations 12 · OpenAlex
  9. The relationship between oxidative stress and autophagy and apoptosis in patients with paroxysmal atrial fibrillation 2022 Citations 12 · OpenAlex
  10. Role of Uremic Toxins on Apoptosis With Varying Periods of Hemodialysis 2017 Citations 5 · OpenAlex

Authors

  1. TUNAY SENTURK
  2. ALI AYDINLAR
  3. YUSUF YILMAZ
  4. ARZU YILMAZTEPE ORAL
  5. OSMAN OZDABAKOGLU
  6. ENGİN ULUKAYA İSTİNYE ÜNİVERSİTESİ